Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-25-000011

Options or other derivatives

  • Chief Executive Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CHRISTOPHER RICHARD · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-15 Grant or award : show line 1 in the form Stock Options +150,000 350,000 D
Loading xslF345X05/primary_doc.xml…